Natalia Curto-Garcia

8PUBLICATIONS
10CO-AUTHORS
Haematological tumoursMolecular targetsMedical microbiology not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 12, 2026
Prognostic Scores and Risk Stratification of Myeloproliferative Neoplasms: 2026 Updates.

|Jul 08, 2022
Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T-cell phenotype.

Patrick Harrington, Richard Dillon, Deepti Radia

|Jun 04, 2021
Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia.

Patrick Harrington, Katie J Doores, Deepti Radia

|Mar 22, 2021
Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre.

Paul Deschamps, Mufaddal Moonim, Deepti Radia

|May 16, 2019
Essential thrombocythaemia treated with recombinant interferon: 'real world' United Kingdom referral centre experience.

Joana Desterro, Donal P McLornan, Natalia Curto Garcia

|Oct 18, 2018
What is pre-fibrotic myelofibrosis and how should it be managed in 2018?

Natalia Curto-Garcia, Jean-Christophe Ianotto, Claire N Harrison

Pageof 2

Frequent Collaborators

6 joint publications

Claire N Harrison

5 joint publications

Donal P McLornan

5 joint publications

Deepti Radia

4 joint publications

Jennifer O'Sullivan